{"id":46018,"date":"2022-07-11T15:01:25","date_gmt":"2022-07-11T13:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/"},"modified":"2022-07-11T15:01:25","modified_gmt":"2022-07-11T13:01:25","slug":"syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/","title":{"rendered":"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities"},"content":{"rendered":"
\n

\nThe combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country<\/i>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThrough this acquisition, Syntellis will expand its suite of intelligent planning and performance solutions by adding Stratasan\u2019s powerful strategic growth capabilities. This combination will deliver unparalleled intelligence and insights to healthcare leaders and create the industry\u2019s most robust set of tools designed to help providers and other healthcare organizations strategically determine where, when and how to grow.\n<\/p>\n

\n\u201cNow more than ever, healthcare organizations need data and intelligence solutions that help them grow profitably and improve outcomes in the face of extraordinary changes and challenges,\u201d said Flint Brenton, CEO of Syntellis. \u201cWith the powerful combination of Syntellis\u2019 leading software, data and intelligence solutions and Stratasan\u2019s advanced analytics and market intelligence, we\u2019ll connect operational, financial and strategic data to empower healthcare leaders to improve their performance, deliver exceptional outcomes and maximize their impact in the communities they serve.\u201d\n<\/p>\n

\nStratasan is a nationally recognized provider of data analytics software and services for hospitals, ancillary care centers, healthcare consultants, and payers, helping them improve the efficiency and effectiveness of strategic growth efforts by delivering advanced market intelligence and data analytics.\n<\/p>\n

\n\u201cFor more than a decade, leading national healthcare organizations have relied on our software and services to provide a clear picture of what’s going on in their target markets \u2014 so they know where to grow,\u201d said Jason Moore, CEO of Stratasan. \u201cWe look forward to furthering our mission as part of Syntellis and continuing to help hospitals and healthcare entities across the country better serve their markets and maximize strategic impact.\u201d\n<\/p>\n

\nThoma Bravo and Madison Dearborn Partners are Syntellis\u2019 primary investors.\n<\/p>\n

\nErnst & Young Global Limited acted as financial advisor and Kirkland & Ellis LLP served as legal advisor to Syntellis. Canaccord Genuity, LLC acted as financial advisor and McDermott Will & Emery LLP served as legal advisor to Stratasan.\n<\/p>\n

\nAbout Syntellis Performance Solutions<\/b>\n<\/p>\n

\nSyntellis Performance Solutions provides innovative enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions. Syntellis\u2019 solutions include Axiom and Connected Analytics software, which help finance professionals elevate performance by acquiring insights, accelerating decisions and advancing their business plans. With over 2,800 organizations and 450,000 users relying on its solutions, Syntellis has proven industry expertise in helping organizations transform their visions into reality. For more information, please visit www.syntellis.com<\/a>.\n<\/p>\n

\nLinkedIn: Syntellis Performance Solutions<\/b><\/a>
<\/b>Twitter: @Syntellis<\/b><\/a>\n<\/p>\n

\nAbout Thoma Bravo<\/b>\n<\/p>\n

\nThoma Bravo is one of the largest private equity firms in the world, with more than $114 billion in assets under management as of March 31, 2022. The firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging the firm\u2019s deep sector expertise and proven strategic and operational capabilities, Thoma Bravo collaborates with its portfolio companies to implement operating best practices, drive growth initiatives and make accretive acquisitions intended to accelerate revenue and earnings. Over the past 20 years, the firm has acquired or invested in more than 380 companies representing over $190 billion in enterprise value. The firm has offices in Chicago, Miami and San Francisco. For more information, visit www.thomabravo.com<\/a>.<\/b>\n<\/p>\n

\nAbout Madison Dearborn Partners, LLC<\/b>\n<\/p>\n

\nMadison Dearborn Partners, LLC (“MDP”) is a leading private equity investment firm based in Chicago. Since MDP’s formation in 1992, the firm has raised aggregate capital of over $28 billion and has completed over 150 investments. MDP invests across five dedicated industry verticals, including health care; basic industries; business and government software and services; financial and transaction services; and telecom, media and technology services. For more information, please visit www.mdcp.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCam Granstra
\n
Syntellis Performance Solutions
\n
872-246-6358
\n
CGranstra@syntellis.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Through … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46018","6":"format-standard","7":"category-industry"},"yoast_head":"\nSyntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Through ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T13:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220711005292\/en\/1509048\/21\/SWIFT-press_release_-_dark.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities\",\"datePublished\":\"2022-07-11T13:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/\"},\"wordCount\":654,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005292\\\/en\\\/1509048\\\/21\\\/SWIFT-press_release_-_dark.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/\",\"name\":\"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005292\\\/en\\\/1509048\\\/21\\\/SWIFT-press_release_-_dark.jpg\",\"datePublished\":\"2022-07-11T13:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005292\\\/en\\\/1509048\\\/21\\\/SWIFT-press_release_-_dark.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005292\\\/en\\\/1509048\\\/21\\\/SWIFT-press_release_-_dark.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities - Pharma Trend","og_description":"The combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country CHICAGO–(BUSINESS WIRE)–Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics. Through ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T13:01:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220711005292\/en\/1509048\/21\/SWIFT-press_release_-_dark.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities","datePublished":"2022-07-11T13:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/"},"wordCount":654,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005292\/en\/1509048\/21\/SWIFT-press_release_-_dark.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/","url":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/","name":"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005292\/en\/1509048\/21\/SWIFT-press_release_-_dark.jpg","datePublished":"2022-07-11T13:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220711005292\/en\/1509048\/21\/SWIFT-press_release_-_dark.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220711005292\/en\/1509048\/21\/SWIFT-press_release_-_dark.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/syntellis-performance-solutions-to-acquire-stratasan-expanding-healthcare-data-analytics-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Syntellis Performance Solutions to Acquire Stratasan, Expanding Healthcare Data Analytics Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46018"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46018\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}